Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system

Edward Bixler, A. Kales, B. H. Brubaker, J. D. Kales

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The rates of reported adverse drug reactions involving the central nervous system were compared among patients taking any of three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. These rates, based upon data collected through the spontaneous reporting system of the Food and Drug Administration, were controlled for the number and size of new prescriptions for each drug. In general, triazolam had much higher overall rates than did the other two drugs. Hyperexcitability and withdrawal effects were greatest for triazolam and least for flurazepam. Amnesia was reported almost exclusively with triazolam. Rates for other cognitive as well as affective and other behavioral effects were also much greater for triazolam and about equal for the other two drugs. Finally, daytime sedation was reported slightly more for flurazepam than triazolam and least for temazepam which was also reported most frequently as lacking hypnotic effect.

Original languageEnglish (US)
Pages (from-to)286-300
Number of pages15
JournalPharmacology
Volume35
Issue number5
DOIs
StatePublished - Jan 1 1987

Fingerprint

Triazolam
Hypnotics and Sedatives
Benzodiazepines
Flurazepam
Temazepam
Amnesia
Prescription Drugs
United States Food and Drug Administration
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Central Nervous System

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Bixler, E., Kales, A., Brubaker, B. H., & Kales, J. D. (1987). Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system. Pharmacology, 35(5), 286-300. https://doi.org/10.1159/000138322
Bixler, Edward ; Kales, A. ; Brubaker, B. H. ; Kales, J. D. / Adverse reactions to benzodiazepine hypnotics : Spontaneous reporting system. In: Pharmacology. 1987 ; Vol. 35, No. 5. pp. 286-300.
@article{2e8576f4ddaf4b73a781959378b08692,
title = "Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system",
abstract = "The rates of reported adverse drug reactions involving the central nervous system were compared among patients taking any of three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. These rates, based upon data collected through the spontaneous reporting system of the Food and Drug Administration, were controlled for the number and size of new prescriptions for each drug. In general, triazolam had much higher overall rates than did the other two drugs. Hyperexcitability and withdrawal effects were greatest for triazolam and least for flurazepam. Amnesia was reported almost exclusively with triazolam. Rates for other cognitive as well as affective and other behavioral effects were also much greater for triazolam and about equal for the other two drugs. Finally, daytime sedation was reported slightly more for flurazepam than triazolam and least for temazepam which was also reported most frequently as lacking hypnotic effect.",
author = "Edward Bixler and A. Kales and Brubaker, {B. H.} and Kales, {J. D.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1159/000138322",
language = "English (US)",
volume = "35",
pages = "286--300",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "5",

}

Bixler, E, Kales, A, Brubaker, BH & Kales, JD 1987, 'Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system', Pharmacology, vol. 35, no. 5, pp. 286-300. https://doi.org/10.1159/000138322

Adverse reactions to benzodiazepine hypnotics : Spontaneous reporting system. / Bixler, Edward; Kales, A.; Brubaker, B. H.; Kales, J. D.

In: Pharmacology, Vol. 35, No. 5, 01.01.1987, p. 286-300.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adverse reactions to benzodiazepine hypnotics

T2 - Spontaneous reporting system

AU - Bixler, Edward

AU - Kales, A.

AU - Brubaker, B. H.

AU - Kales, J. D.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - The rates of reported adverse drug reactions involving the central nervous system were compared among patients taking any of three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. These rates, based upon data collected through the spontaneous reporting system of the Food and Drug Administration, were controlled for the number and size of new prescriptions for each drug. In general, triazolam had much higher overall rates than did the other two drugs. Hyperexcitability and withdrawal effects were greatest for triazolam and least for flurazepam. Amnesia was reported almost exclusively with triazolam. Rates for other cognitive as well as affective and other behavioral effects were also much greater for triazolam and about equal for the other two drugs. Finally, daytime sedation was reported slightly more for flurazepam than triazolam and least for temazepam which was also reported most frequently as lacking hypnotic effect.

AB - The rates of reported adverse drug reactions involving the central nervous system were compared among patients taking any of three benzodiazepine hypnotics: flurazepam, temazepam, and triazolam. These rates, based upon data collected through the spontaneous reporting system of the Food and Drug Administration, were controlled for the number and size of new prescriptions for each drug. In general, triazolam had much higher overall rates than did the other two drugs. Hyperexcitability and withdrawal effects were greatest for triazolam and least for flurazepam. Amnesia was reported almost exclusively with triazolam. Rates for other cognitive as well as affective and other behavioral effects were also much greater for triazolam and about equal for the other two drugs. Finally, daytime sedation was reported slightly more for flurazepam than triazolam and least for temazepam which was also reported most frequently as lacking hypnotic effect.

UR - http://www.scopus.com/inward/record.url?scp=0023233229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023233229&partnerID=8YFLogxK

U2 - 10.1159/000138322

DO - 10.1159/000138322

M3 - Article

C2 - 2892212

AN - SCOPUS:0023233229

VL - 35

SP - 286

EP - 300

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 5

ER -